JMS Co

JMS Co Gross Margin

The Gross Margin of JMS Co (7702.T) as of Nov 2, 2026 is 23.32 %. In the previous year, Gross Margin was 22.83 % — a change of 2.14% (higher).

Gross Margin

23.32 %

YoY

2.14%

Last updated:

Gross Margin of JMS Co is 2026 23.32 % . Gross Margin of JMS Co was 2025 22.83 % . It decreases by 2.14% higher compared to the previous year.

JMS Co's gross margin stands at 23.3%, down from 24.5% several years earlier.

The JMS Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2019
25.52 JPY
Jan 1, 2020
26.70 JPY
Jan 1, 2021
26.22 JPY
Jan 1, 2022
24.53 JPY
Jan 1, 2023
22.90 JPY
Jan 1, 2024
21.59 JPY
Jan 1, 2025
22.83 JPY
Jan 1, 2026
23.32 JPY
The JMS Co Gross Margin history
YEARGross MarginYoY
23.32 %+2.14%
22.83 %+5.77%
21.59 %-5.73%
22.90 %-6.66%
24.53 %-6.43%
26.22 %-1.81%
26.70 %+4.61%
25.52 %+1.01%
25.27 %-2.72%
25.97 %+0.70%
25.79 %+6.23%
24.28 %-3.99%
25.29 %+9,135.71%
0.27 %+0.68%
0.27 %-6.25%
0.29 %-3.86%
0.30 %+2.40%
0.29 %+0.65%
0.29 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Gross Margin of JMS Co is 23.32 % in 2026.

Gross Margin of JMS Co changed from 22.83 % to 23.32 %, representing a 2.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin JMS Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's JMS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — JMS Co

All Key Metrics — JMS Co